HTA Details

Genetic Testing for Predisposition to Dilated Cardiomyopathy

Publication date
2012-March-01
Status
Final
Topic Area
Genetics
Recommendation

Ontario Health Technology Advisory Committee Recommendation:

  • The Ontario Health Technology Advisory Committee does not recommend access to genetic testing for dilated cardiomyopathy for individuals diagnosed with this disease or for their immediate or extended family members
Ministry Response
The Ministry of Health and Long Term Care accepted this recommendation when it was submitted in 2012.

To read the full OHTAC Recommendation Report for this topic, contact our Health Innovation team using the contact form to request a digital copy.

Dilated cardiomyopathy is a disease of the heart muscle. It can cause the heart’s main pumping chamber (left ventricle) to stretch; as a result it can’t pump blood as well as it should. Dilated cardiomyopathy is a leading cause of irregular heartbeat (arrhythmia) and heart failure; however, the condition is largely underdiagnosed and often discovered late in the course of disease, once clinical symptoms are present.

Genetic testing is primarily meant to identify whether an individual carries a disease-causing mutation (a DNA sequence that differs from what is found in most people) that could be common among family members. Family members with this mutation who do not show symptoms of the disease may be at risk of developing dilated cardiomyopathy later in life. Identification of these high-risk family members could allow for heightened medical monitoring and early management if symptoms appear.

Supporting Documents

Last Updated: February 24, 2026